Xilio Therapeutics Inc. (XLO)

0.91

0.00 (0.44%)

At close: Mar 03, 2025, 3:59 PM

0.86

-5.15%

After-hours: Mar 03, 2025, 04:37 PM EST

Xilio Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-76.4M	-88.22M	-75.8M	-55.22M	-17.31M
Depreciation & Amortization	1.9M	1.85M	1.5M	1.06M	240K
Stock-Based Compensation	7.38M	8.42M	4.96M	1.3M	112K
Other Working Capital	2.47M	1.52M	-8.98M	13.68M	-173K
Other Non-Cash Items	-3.97M	224K	173K	39K	56K
Deferred Income Tax	2.06M	n/a	222K	126K	-1.74M
Change in Working Capital	405K	2M	-11.8M	16.6M	797K
Operating Cash Flow	-68.62M	-75.72M	-80.75M	-36.09M	-17.84M
Capital Expenditures	-486K	-1.87M	-1.1M	-2.19M	-715K
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-486K	-1.87M	-1.1M	-2.19M	-715K
Debt Repayment	-6.75M	-85K	-110K	-99K	9.95M
Common Stock Repurchased	194K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	202K	16K	144.42M	10.13M	40.12M
Financial Cash Flow	-6.55M	-69K	260.67M	10.03M	60.02M
Net Cash Flow	-75.66M	-77.66M	178.82M	-28.25M	41.46M
Free Cash Flow	-69.11K	-77.59M	-81.85M	-38.28M	-18.56M